Angiodynamics (ANGO) Free Cash Flow (2010 - 2026)

Angiodynamics has reported Free Cash Flow for 17 years, with the latest figure at -$4.5 million in Q1 2026.

• For the quarter ending Q1 2026, Free Cash Flow rose 69.29% year-over-year to -$4.5 million; the trailing twelve-month figure through Feb 2026 stood at $1.3 million (up 104.73% YoY), and the FY2025 full-year result was -$14.6 million, up 52.43% from the prior year.
• Free Cash Flow for Q1 2026 stood at -$4.5 million, down from $4.2 million in the prior quarter.
• The five-year high for Free Cash Flow was $18.2 million in Q2 2025, with the low at -$27.0 million in Q3 2022.
• Historically, Free Cash Flow has averaged -$4.0 million across 5 years, with a median of -$110000.0 in 2023.
• Annual changes were most pronounced in 2022 — Free Cash Flow surged 675.8% — and 2024, when it sank 11238.18%.
• Angiodynamics' Free Cash Flow stood at $6.3 million in 2022, then tumbled by 35.53% to $4.1 million in 2023, then slumped by 73.14% to $1.1 million in 2024, then jumped by 289.61% to $4.2 million in 2025, then tumbled by 205.4% to -$4.5 million in 2026.
• The last three Free Cash Flow figures came in at -$4.5 million (Q1 2026), $4.2 million (Q4 2025), and -$16.6 million (Q3 2025), per Business Quant data.